1. Service Overview & Global Regulatory Compliance Framework
As leading integrated design-build general contractors headquartered in China, we deliver full-lifecycle turnkey construction solutions exclusively for biopharmaceutical manufacturing plants, covering conceptual layout design, cleanroom construction, sanitary equipment procurement, on-site installation, commissioning and compliance validation. All engineering deliverables are developed in strict alignment with NMPA GMP, FDA cGMP, EMA Annex 1, PIC/S and ICH Q8/Q9/Q10 unified global biomanufacturing standards, catering to full-spectrum biotech production scenarios including monoclonal antibodies, ADCs, recombinant therapeutic proteins, viral vaccines and sterile injectables. Distinct from fragmented local construction vendors and overpriced Western engineering firms, our Chinese design-build model vertically integrates bioprocess technical R&D, in-house equipment manufacturing and standardized construction execution, eliminating disjointed design-procurement-construction workflows and cross-party communication risks. We have completed hundreds of domestic and overseas biopharma factory projects across Southeast Asia, the Middle East, Africa and Latin America, providing audit-ready, cost-optimized plant construction solutions for biotech startups and multinational pharmaceutical manufacturers alike.
2. Core Design-Build Philosophy & Unique Competitive Advantages
Rooted in risk-based quality management and process-driven deterministic engineering logic consistent with our full series technical standards, our Chinese design-build team centers all construction planning on bioprocess CPPs and product-specific CQAs to avoid post-construction compliance retrofits. Our core competitive strengths derive from vertical industrial integration unique to Chinese biopharma engineering supply chains: independent R&D and production of sanitary 316L stainless steel bioprocess equipment, self-owned cleanroom panel and HVAC manufacturing bases, and mature localized construction teams with decades of GMP facility execution experience. We embed FMEA contamination risk assessment, unidirectional personnel/material flow zoning and graded cleanroom pressure gradient control into early-stage BIM 3D design, resolving critical pain points such as microbial cross-contamination, protein denaturation risks and airflow turbulence defects. Compared with Western design-build contractors, we deliver equivalent international compliance standards with 20–35% lower overall project investment, shorter construction cycles and flexible localized after-sales technical support across global emerging biomanufacturing markets.
3. Integrated Four Core Design-Build Functional Modules
Our standardized Chinese biopharma plant design-build system comprises four synergistic full-process service modules covering the entire project delivery chain: bioprocess customized design module, regulated global procurement module, classified cleanroom construction module and post-handover compliance validation module. The design module adopts BIM digital modeling for whole-plant layout, upstream/downstream process pipeline routing, Grade A/B/C/D cleanroom zoning and utility system matching, fully simulating actual production workflows before construction commencement. The procurement module leverages China’s complete biopharma equipment industrial chain to source GMP-certified bioreactors, medium preparation tanks, chromatography systems and WFI water treatment units, with strict vendor qualification audits for all process hardware. The construction module executes classified aseptic workshop sealing, sanitary pipeline welding, HVAC purification installation and MEP utility integration with dedicated GMP construction specifications. The validation module outputs complete DQ/IQ/OQ/PQ qualification archives, PIC/S-aligned risk assessment reports and standardized SOP guidance to support seamless regulatory inspection readiness post-delivery.
4. Global Industrial Deployment & Full Lifecycle International Support
Our Chinese biopharma design-build contracting services are widely deployed for new commercial factory construction, pilot workshop scale-up, old facility compliance renovation and capacity expansion projects for global biotech clients, fully adaptable to small-batch clinical trial production and large-volume continuous commercial biomanufacturing. The modular, scalable design-build architecture reserves expansion interfaces for future process iteration, high-titer cell culture upgrading and multi-product flexible production switching without large-scale reconstruction work. We provide cross-border full-lifecycle technical support spanning pre-project process consulting, overseas on-site construction supervision, multi-language operator compliance training, regular facility maintenance and long-term production line optimization consulting. As trusted Chinese biopharma engineering partners with multi-country project delivery track records, we help global clients balance construction capital control, on-time project delivery and international regulatory compliance, lowering overall industrialization costs and accelerating the global commercial launch of innovative biologic drugs.
